Brief summary of the agreement
Anyone is free:
· to copy, distribute, and display the work;
· to make derivative works;
· to make commercial use of the work;
Under the following conditions: Attribution
· the original author must be given credit;
· for any reuse or distribution, it must be made clear to others what the license terms of this work are;
· any of these conditions can be waived if the authors gives permission.
Statutory fair use and other rights are in no way affected by the above
Author Biographies
Bilal Sula
Department of Dermatology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
Feyzullah Uçmak
Department of Gastroenterology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
Mehmet Ali Kaplan
Department of Medical Oncology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
Zuhat Urakçi
Department of Medical Oncology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
Mustafa Arica
Department of Dermatology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
Abdurrahman Isikdogan
Department of Medical Oncology, Faculty of Medicine, Dicle University, Diyarbakir, Turkey
Main Article Content
Epidemiological and clinical characteristics of malignant melanoma in Southeast Anatolia in Turkey
Bilal Sula
Feyzullah Uçmak
Mehmet Ali Kaplan
Zuhat Urakçi
Mustafa Arica
Abdurrahman Isikdogan
Abstract
Introduction: The present study aimed to establish the epidemiological and clinical characteristics of patients who were histopathologically diagnosed with malignant melanoma (MM). Methods: The present study retrospectively analyzed the data of 78 patients who were histopathologically diagnosed with MM in Dicle University Medical Faculty, Dermatology and Medical Oncology departments between 2005 and 2014. Results: The study included 78 patients in total with 44 (56.4%) male and 34 (43.6%) female. Median age of the patients was 62.50 years (range: 27 - 84 years). Of the patients, 78.2% (n=61) had cutaneous melanoma, 8.9% had solid organ melanoma, and 2.5% had ocular and mucosal melanoma. The most common tumor localization among the patients was the lower extremities with 29.4% (n=23). The most common histopathological type was nodular malignant melanoma with 35.8% (n=28). Based on TNM, Clark and Breslow classifications, 26.9% (n=21) of the patients were stage 4, 26.9% (n=21) were Clark stage 4, and 37.1% (n=29) were Breslow stage 4. Median overall survival in all patients was 14.9 months (95% CI 10.9 - 18.8 months). In the multivariate Cox analysis, only stage statistically significantly affecting survival [odds ratio (OR): 0.54; (95% CI 0.16-1.82, p=0.02)]. Conclusion: Malignant melanoma data are also important for the optimal utilization of effective methods and healthcare resources to prevent the disease. In order to minimize MM mortality and morbidity, not only the society but also physicians from primary and secondary care hospitals should become familiar with melanoma.
Pan African Medical Journal 2016; 24
Donate
AJOL is a Non Profit Organisation that cannot function without donations.
AJOL and the millions of African and international researchers who rely on our free services are deeply grateful for your contribution.
AJOL is annually audited and was also independently assessed in 2019 by E&Y.
Your donation is guaranteed to directly contribute to Africans sharing their research output with a global readership.
Once off donations here:
For annual AJOL Supporter contributions, please view our Supporters page.
Tell us what you think and showcase the impact of your research!
Please take 5 minutes to contribute to our survey so that we can better understand the contribution that African research makes to global and African development challenges. Share your feedback to help us make sure that AJOL's services support and amplify the voices of researchers like you.